These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 28407660)

  • 1. The Effects of Calcium, Vitamins D and K co-Supplementation on Markers of Insulin Metabolism and Lipid Profiles in Vitamin D-Deficient Women with Polycystic Ovary Syndrome.
    Karamali M; Ashrafi M; Razavi M; Jamilian M; Akbari M; Asemi Z
    Exp Clin Endocrinol Diabetes; 2017 May; 125(5):316-321. PubMed ID: 28407660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
    Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
    Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Vitamin D-K-Calcium Co-Supplementation on Endocrine, Inflammation, and Oxidative Stress Biomarkers in Vitamin D-Deficient Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Razavi M; Jamilian M; Karamali M; Bahmani F; Aghadavod E; Asemi Z
    Horm Metab Res; 2016 Jul; 48(7):446-51. PubMed ID: 27050252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Trial on The Effects of Magnesium-Zinc-Calcium-Vitamin D Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome.
    Jamilian M; Maktabi M; Asemi Z
    Arch Iran Med; 2017 Oct; 20(10):640-645. PubMed ID: 29137465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization.
    Dastorani M; Aghadavod E; Mirhosseini N; Foroozanfard F; Zadeh Modarres S; Amiri Siavashani M; Asemi Z
    Reprod Biol Endocrinol; 2018 Oct; 16(1):94. PubMed ID: 30286768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of vitamin D and evening primrose oil co-supplementation on lipid profiles and biomarkers of oxidative stress in vitamin D-deficient women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
    Nasri K; Akrami S; Rahimi M; Taghizadeh M; Behfar M; Mazandaranian MR; Kheiry A; Memarzadeh MR; Asemi Z
    Endocr Res; 2018 Feb; 43(1):1-10. PubMed ID: 28742409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Foroozanfard F; Jamilian M; Jafari Z; Khassaf A; Hosseini A; Khorammian H; Asemi Z
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):215-20. PubMed ID: 25868059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency.
    Ardabili HR; Gargari BP; Farzadi L
    Nutr Res; 2012 Mar; 32(3):195-201. PubMed ID: 22464806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnesium-Zinc-Calcium-Vitamin D Co-supplementation Improves Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial.
    Maktabi M; Jamilian M; Asemi Z
    Biol Trace Elem Res; 2018 Mar; 182(1):21-28. PubMed ID: 28668998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Maktabi M; Chamani M; Asemi Z
    Horm Metab Res; 2017 Jul; 49(7):493-498. PubMed ID: 28679140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Foroozanfard F; Talebi M; Samimi M; Mehrabi S; Badehnoosh B; Jamilian M; Maktabi M; Asemi Z
    Horm Metab Res; 2017 Aug; 49(8):612-617. PubMed ID: 28679142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome.
    Rahmani E; Samimi M; Ebrahimi FA; Foroozanfard F; Ahmadi S; Rahimi M; Jamilian M; Aghadavod E; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z
    Mol Cell Endocrinol; 2017 Jan; 439():247-255. PubMed ID: 27619403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial.
    Foroozanfard F; Jamilian M; Bahmani F; Talaee R; Talaee N; Hashemi T; Nasri K; Asemi Z; Esmaillzadeh A
    Clin Endocrinol (Oxf); 2015 Dec; 83(6):888-94. PubMed ID: 26119844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Magnesium and Vitamin E Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M; Sabzevar NK; Asemi Z
    Horm Metab Res; 2019 Feb; 51(2):100-105. PubMed ID: 30286483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.
    Javed Z; Papageorgiou M; Deshmukh H; Kilpatrick ES; Mann V; Corless L; Abouda G; Rigby AS; Atkin SL; Sathyapalan T
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30658483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial.
    Seyyed Abootorabi M; Ayremlou P; Behroozi-Lak T; Nourisaeidlou S
    Gynecol Endocrinol; 2018 Jun; 34(6):489-494. PubMed ID: 29271278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M; Asemi Z
    Ann Nutr Metab; 2015; 67(1):42-8. PubMed ID: 26279073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Indices of Insulin Resistance and Hormonal Parameters in Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Ebrahimi FA; Samimi M; Foroozanfard F; Jamilian M; Akbari H; Rahmani E; Ahmadi S; Taghizadeh M; Memarzadeh MR; Asemi Z
    Exp Clin Endocrinol Diabetes; 2017 Jun; 125(6):353-359. PubMed ID: 28407657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review.
    Menichini D; Facchinetti F
    Gynecol Endocrinol; 2020 Jan; 36(1):1-5. PubMed ID: 31187648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z
    Exp Clin Endocrinol Diabetes; 2018 Apr; 126(4):222-228. PubMed ID: 29117618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.